Research / JBL / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-19-097892 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
43.80% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.04% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
3.29% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
14.45% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
53.54% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
7.50% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
2.54% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.17% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.26% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Nov 30, 2019 0/9 normalized Level 3 Feb 29, 2020 8/9 normalized Level 3 May 31, 2020 8/9 normalized Level 3 Aug 31, 2020 8/9 normalized Level 3 Nov 30, 2020 8/9 normalized Level 3 Feb 28, 2021 9/9 normalized Level 3 May 31, 2021 9/9 normalized Level 3 Aug 31, 2021 9/9 normalized Level 3 Nov 30, 2021 9/9 normalized Level 3 Feb 28, 2022 9/9 normalized Level 3 May 31, 2022 9/9 normalized Level 3 Aug 31, 2022 9/9 normalized Level 3 Nov 30, 2022 9/9 normalized Level 3 Feb 28, 2023 9/9 normalized Level 3 May 31, 2023 9/9 normalized Level 3 Aug 31, 2023 9/9 normalized Level 3 Nov 30, 2023 9/9 normalized Level 3 Feb 29, 2024 9/9 normalized Level 3 May 31, 2024 9/9 normalized Level 3 Aug 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 38.24%
Current 43.80%
Delta 5.57% Capex Intensity Increased
Previous 3.56%
Current 5.04%
Delta 1.48% Cash Generation Increased
Previous -1.41%
Current 3.29%
Delta 4.70% Inventory Pressure Increased
Previous 49.41%
Current 53.54%
Delta 4.13% Margin Decreased
Previous 7.99%
Current 7.50%
Delta -0.49% Profitability Decreased
Previous 3.33%
Current 2.54%
Delta -0.79% R And D Intensity Decreased
Previous 0.17%
Current 0.17%
Delta -0.00% Sbc Intensity Decreased
Previous 0.27%
Current 0.26%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.